Literature DB >> 6617711

Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid.

A Gaucher, P Netter, G Faure, J P Schoeller, A Gerardin.   

Abstract

The diffusion of oxyphenbutazone into synovial and cerebrospinal fluids and synovium and joint cartilage was investigated in 25 patients receiving short-term treatment. In the synovial fluid, the mean oxyphenbutazone concentration, was 57.1 +/- 13.4% of the plasma level, due to its excellent diffusion into the joint cavity. In synovial tissue, the oxyphenbutazone level was higher in patients with severe inflammation than in those with no or little inflammation. Penetration into joint cartilage is less than into synovial tissue. In cerebrospinal fluid the concentration was close to the level of free plasma oxyphenbutazone. The findings show increased diffusion of oxyphenbutazone towards its site of action in inflammation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617711     DOI: 10.1007/bf00544025

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations.

Authors:  T M Chalmers; R C Glass; P C Risdall
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

2.  The passage of benorylate into the synovial fluid and tissue of rheumatoid patients.

Authors:  V A Laine; R G Penn; H Pätiälä; R Sibelius
Journal:  Scand J Rheumatol Suppl       Date:  1975

3.  [The distribution of benorylate in plasma, synovial fluid and synovial tissue in rheumatoid arthritis].

Authors:  G Manz; J P Glynn
Journal:  Z Rheumatol       Date:  1975 Nov-Dec       Impact factor: 1.372

4.  [On biochemistry and pharmacokinetics of etofenamate/studies in man (author's transl)].

Authors:  H D Dell; J Fiedler; H Jacobi; B Wäsche
Journal:  Arzneimittelforschung       Date:  1977

5.  Pharmacokinetics of carprofen in plasma and synovial fluid.

Authors:  J E Ray; D N Wade; G G Graham; R O Day
Journal:  J Clin Pharmacol       Date:  1979-10       Impact factor: 3.126

6.  Concentrations of ibuprofen in serum and synovial fluid from patients with arthritis [proceedings].

Authors:  R C Glass; A J Swannell
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

7.  Some observations and speculations on the factors influencing the concentration of phenylbutazone in synovial fluid.

Authors:  M Farr; C F Hawkins; M J Kendall; J V Willis
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-12

8.  [Tissue concentrations of non-steroidal anti-inflammatory agents in chronic polyarthritis patients].

Authors:  G Köhler; H D Dell; R Kamp
Journal:  Z Rheumatol       Date:  1981 Mar-Apr       Impact factor: 1.372

9.  Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis.

Authors:  I Caruso; E Moro; C Patrono; G Sacchetti; V Tamassia; G P Tosolini
Journal:  Scand J Rheumatol       Date:  1980       Impact factor: 3.641

10.  Dissociation of acetylsalicylic acid in blood and joint fluid.

Authors:  A Soren
Journal:  Scand J Rheumatol       Date:  1977       Impact factor: 3.641

View more
  10 in total

Review 1.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

2.  Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells.

Authors:  F Lapicque; P Vergne; J Y Jouzeau; D Loeuille; P Gillet; E Vignon; P Thomas; P Velicitat; D Türck; C Guillaume; A Gaucher; P Bertin; P Netter
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

Review 3.  Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping.

Authors:  G A Ellis; D R Blake
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

4.  Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.

Authors:  Ben Gold; Maneesh Pingle; Steven J Brickner; Nilesh Shah; Julia Roberts; Mark Rundell; W Clay Bracken; Thulasi Warrier; Selin Somersan; Aditya Venugopal; Crystal Darby; Xiuju Jiang; J David Warren; Joseph Fernandez; Ouathek Ouerfelli; Eric L Nuermberger; Amy Cunningham-Bussel; Poonam Rath; Tamutenda Chidawanyika; Haiteng Deng; Ronald Realubit; J Fraser Glickman; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 5.  Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy.

Authors:  K McCormack; K Brune
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

6.  D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.

Authors:  D A Joyce; R O Day
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

7.  Effects of certain antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures.

Authors:  G R Srinivas; C O Chichester; H J Barrach; A L Matoney
Journal:  Agents Actions       Date:  1994-05

8.  Tenoxicam concentrations in synovium and joint cartilage in humans.

Authors:  B Bannwarth; P Netter; F Lapicque; D Mainard; P Fener; P Gillet; A Gaucher
Journal:  Agents Actions       Date:  1991-03

Review 9.  A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.

Authors:  L S Nuutinen; J O Laitinen; T E Salomäki
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

10.  Diffusion of intramuscular ketoprofen into the cerebrospinal fluid.

Authors:  P Netter; F Lapicque; B Bannwarth; J N Tamisier; P Thomas; R J Royer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.